Propanc Biopharma (PPCB) Prepaid Assets (2011 - 2025)
Propanc Biopharma (PPCB) posted quarterly Prepaid Assets of $7.1 million for Q4 2025, up 517120.1% year-over-year from N/an in Q4 2024, and up 80635.08% quarter-over-quarter from $8828.0 in Q3 2025.
Propanc Biopharma (PPCB) Prepaid Assets (2011 - 2025) Analysis & Trends
Propanc Biopharma (PPCB) has reported Prepaid Assets for 13 consecutive years, with $7.1 million the latest figure, recorded in Q4 2025.
- In Q4 2025, Prepaid Assets rose 517120.1% year-over-year to $7.1 million; the TTM figure through Dec 2025 stood at $7.1 million (up 517120.1% YoY), while the FY2025 annual figure was $1380.0, down 1.85% from the prior year.
- Prepaid Assets improved to $7.1 million in Q4 2025 per PPCB's latest filing, from $8828.0 in the prior quarter.
- Across five years, Prepaid Assets topped out at $7.1 million in Q4 2025 and bottomed at $1312.0 in Q1 2025.
- Historically, Prepaid Assets has averaged $427208.8 across 5 years, with a median of $8405.0 in 2022.
- Annual changes were most pronounced in 2024 — Prepaid Assets slumped 88.65% — and 2025, when it soared 517120.1%.
- Propanc Biopharma's Prepaid Assets stood at $5637.0 in 2021, then jumped by 347.17% to $25207.0 in 2022, then slumped by 51.84% to $12139.0 in 2023, then plunged by 88.65% to $1378.0 in 2024, then jumped by 517120.1% to $7.1 million in 2025.
- Business Quant data shows PPCB's Prepaid Assets at $7.1 million in Q4 2025, $8828.0 in Q3 2025, and $1380.0 in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.89 Bn | 131.04 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 86.05 Bn | 78.06 Bn | 3.93 Bn |
| 3 | Argenx Se | 65.56 Bn | 60.38 Bn | 1.37 Bn |
| 4 | Moderna | 55.46 Bn | 50.32 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 42.12 Bn | 37.02 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.62 Bn | 28.31 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.70 Bn | 9.30 Bn | 668.28 Mn |
| 8 | Insmed | 27.51 Bn | 26.35 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.38 Bn | 26.54 Bn | - |
| 10 | Propanc Biopharma | 577,167.14 | 577,167.14 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.13 Mn |
| Sep 30, 2025 | 8,828.00 |
| Jun 30, 2025 | 1,380.00 |
| Mar 31, 2025 | 1,312.00 |
| Dec 31, 2024 | 1,378.00 |
| Sep 30, 2024 | 8,957.00 |
| Jun 30, 2024 | 1,406.00 |
| Mar 31, 2024 | 1,368.00 |
| Dec 31, 2023 | 12,139.00 |
| Sep 30, 2023 | 20,376.00 |
| Jun 30, 2023 | 6,125.00 |
| Dec 31, 2022 | 25,207.00 |
| Sep 30, 2022 | 15,765.00 |
| Jun 30, 2022 | 8,621.00 |
| Mar 31, 2022 | 8,405.00 |
| Dec 31, 2021 | 5,637.00 |
| Sep 30, 2021 | 8,353.00 |
| Dec 31, 2019 | 6,334.00 |
| Sep 30, 2019 | 45,838.00 |
| Jun 30, 2019 | 83,299.00 |